CBD & Inflammation: A Case StudySep 30, 2021 06:31PM ● By Joe Condora
As CBD products continue to rise in popularity, countless manufacturers are beginning to join the trend. You can find a plethora of different types of CBD products on the market from oils, gummies, lotions, bath bombs, and even CBD infused water. Along with the increase comes health promises that often under deliver.
Hopeful patients find themselves looking for relief by using CBD oil for inflammation, anxiety and sleep support. Unfortunately, most CBD companies are favoring profit margins over improved patient health outcomes, leaving individuals still suffering and believing that CBD is ineffective. Often times, patients don’t get the results they are looking for when taking CBD due to the fact that companies are using cheap ingredients and manufacturing methods to create their products. These cheap, ineffective products lead individuals to the conclusion that CBD oil is a new, trendy supplement without scientific literature backing its efficacy.
In reality, a significant body of clinical research has been published suggesting that CBD oil can be utilized as an effective tool to manage anxiety and inflammatory based conditions.
A common misunderstanding in individuals taking these products is that a higher dose equals a more effective dose. When it comes to CBD, more does not always equal better. In fact, taking more CBD than you need can render your therapy ineffective. It’s important to speak with a qualified health professional to review personal health history, medication use, and several other factors that can determine the proper dosage for the individual.
Inflammatory related conditions like arthritis are on the rise, with more than 50 million Americans above the age of 18 being diagnosed with arthritis between 2007 and 2009. Inflammation also plays a role in cardiovascular disease, cancer, and diabetes, as well as other conditions. Various nutraceuticals have been examined to assess their effectiveness in managing inflammation with mixed results. CBD is being investigated as a potentially powerful therapeutic treatment for patients with a various inflammatory related conditions.
In June of 2021, a case study was published in the Cannabis Cannabinoid Research journal. The study aimed to assess the impact that CBD oil has on various inflammatory markers.
The study included a systematic review of 26 different published papers. Only studies that evaluated the effect of cannabinoids on inflammatory markers in animal models were included in the review. The study also compared the effect of different cannabinoids including CBD, CBG, and THC on the inflammatory response in the animal models. It also examined the effect that CBD, CBG and THC each have separately on inflammatory markers. The study then assessed the impact of a CBD and THC combination.
The researchers concluded that key inflammatory markers including tumor necrosis factor alpha, interleukin (IL)-1β, IL-6, and interferon gamma were significantly reduced after treatment with CBD, CBG, or CBD+THC, but not with THC alone.
While each of the components that are found in the hemp plant have their own unique benefits, this research confirms previous research showing that THC is largely ineffective for inflammation management. The research suggests that CBD works synergistically with CBG and THC to yield the best results in reducing key inflammatory markers.
Joe Condora is the Nutrition & Health Coach at Valley Integrative Pharmacy. His specialties include nutraceutical counseling and creating personalized meal plans for clients to achieve optimal wellness.
Location: 75 Washington Valley Rd., Bedminster. Call Valley Integrative Pharmacy to discuss which CBD product formulation is most suitable for you and your needs. 908-658-4900. ValleyPharmacyRX.com. See ad, page 3.
We stress the core value that the patient is the center of all wellness activity and is the key stakeholder and decision maker with respect to his/her health. Our purpose is to facilitate... Read More »